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Abstract In the present article, we aimed to compare the
cardiometabolic risk between overweight children with and
without type 1 diabetes (T1DM). Therefore, data with
regard to cardiometabolic risk parameters of 44 overweight
Caucasian children (3–18 years) with T1DM were matched
with 44 overweight peers without T1DM for sex, ethnicity,
age and standard deviation score of BMI (Z-BMI). Detailed
history was taken, information regarding anthropometrics and
family history were collected and blood pressure was
measured. Blood samples were collected for evaluation of
lipid profiles (fasting in controls, non-fasting in T1DM
children), alanine aminotransferase and HbA1c (in children
with T1DM). It was found that overweight children with
T1DM had lower median standard deviation score of waist
circumference (Z-WC) as compared to the overweight control
group [median, 2.0 (interquartile range, IQR, 1.5–2.3) vs. 2.6
(IQR, 2.0–2.9), P<0.001]. After adjustment for Z-WC, in
children with T1DM, median high-density lipoprotein
cholesterol levels were significantly higher and median
low-density lipoprotein cholesterol lower in T1DM children,
as compared to their peers without T1DM [1.40 (IQR, 1.2–
1.5) vs. 1.2 (IQR, 1.0–1.3) and 2.7 (IQR, 2.5–3.2) vs. 3.0
(IQR, 2.5–3.4), respectively, all P<0.01]. When dividing
children according to glycaemic status, children with
suboptimal glycaemic control had higher values of trigly-
cerides as compared to well-controlled children [1.3 (IQR,
1.0–1.8) vs. 0.96 (IQR, 0.80–1.2), P=0.036]. In conclusion,
overweight children with T1DM have a more favourable
lipid profile, as compared to non-diabetic overweight
controls, in spite of a higher frequency of a positive family
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DOI 10.1007/s00431-011-1574-7history of CVD, T2DM and hypertension. Still, paediatri-
cians should give extra attention to cardiometabolic risk
factors within this vulnerable group, taking into account the
already high cardiometabolic risk.
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for cardiovascular disease.Type 1 diabetes
Introduction
In line with the global obesity epidemic, an increasing
proportion of children becomes overweight and may
develop additional cardiometabolic risk factors, including
dyslipidaemia, high blood pressure and glucometabolic
disorders [19, 23]. Unless children are encouraged to lose
weight successfully, many cardiometabolic risk factors that
emerge during childhood persist throughout adulthood and
may ultimately lead to premature death [3, 5, 11]. Although
the effect of overweight has been studied extensively in the
general population, the effect of weight gain on cardiome-
tabolic health in individuals with type 1 diabetes (T1DM)
remains largely unknown. According to the SEARCH for
Diabetes in Youth study, a higher proportion of children
with T1DM are overweight (but not obese) as compared to
non-diabetic controls, suggesting co-occurrence of different
mechanisms, which lead to weight gain in subjects with
T1DM [9]. Next to a sedentary lifestyle, other factors may
highly promote weight gain in T1DM patients, such as
intensified insulin therapy to optimise glycaemic control
[1]. Although there is a lack of studies investigating the
relationship of causes of weight gain (i.e., intensified
insulin treatment for glycaemic control vs. sedentary
lifestyle) with the development of cardiometabolic risk
factors, it has been reported in the Diabetes Control and
Complications Trial (DCCT) that the development of
overweight in individuals with T1DM caused similar
adverse changes in cardiometabolic risk [14]. As these
cardiometabolic changes have their onset in childhood, they
will promote the process of atherosclerosis in both non-
diabetic children and children with T1DM. Interestingly,
however, the latter group tends to develop more severe
atherosclerotic lesions starting earlier in life as compared to
non-diabetic controls [15]. In a previous study, we
demonstrated that both overweight non-diabetic children
and children with T1DM have a high prevalence of
cardiometabolic risk factors. As compared to their normal
weightpeerswithT1DM,overweightchildrenwithoutT1DM
had a higher prevalence of the metabolic syndrome, isolated
hypertension and high alanine aminotransferase (ALT) [22].
In the present study, we compare overweight children with
and without T1DM, with respect to cardiometabolic risk
variables, after matching for sex, age, standard deviation
score of BMI (Z-BMI) and ethnicity.
Materials and methods
Selection of T1DM and non-T1DM children
In 2007 and 2008, data from 283 children with T1DM, who
visited a specialised clinic for paediatric diabetes care
(Diabeter), were collected for cross-sectional analysis for
cardiometabolic risk factors, as described previously [22].
From this data set (n=99; Z-BMI, −2 . 5t o4 . 1 ) ,a l l
Caucasian children with overweight were selected and
matched according to sex, age, ethnicity (i.e. being
Caucasian) and Z-BMI to non-diabetic children derived
from a data set (n=750; Z-BMI, 1.4–4.2) from a paediatric
obesity clinic (Slotervaart Hospital) in Amsterdam, The
Netherlands. Children of the latter group were excluded
from the study when using glucose- or lipid-lowering
drugs, corticosteroids (chronically) or drugs acting on the
central nervous system. Additionally, children with (sus-
pected) syndromes, T1DM, type 2 diabetes (T2DM) or
secondary causes of obesity, such as hypothyroidism,
hypogonadism and pituitary disorders, were excluded [21].
In total, 44 successful matches could be made.
Definitions
Overweight was classified using standardised scores of
BMI (Z-BMI), according to the Dutch Fourth National
Growth Study, with a cut-off value for overweight being a
Z-BMI≥1.1 [6]. A detailed history was taken [including
family history for T2DM, premature cardiovascular disease
(CVD) and hypertension according to the criteria of the
American Diabetes Association] [2] and anthropometrics
were recorded. Three consecutive blood pressure measure-
ments were performed at the non-dominant arm, with at
least 1-min interval, in the seated position and after 10 min
of rest. The mean of these three measurements was used in
the analyses. Furthermore, blood samples were drawn for
evaluation of lipid profiles and ALT. This was done in the
non-fasting state (due to both ethical and practical reasons)
in children with T1DM [22] and in the fasting state in
children from the control group [21]. Since lipid levels
were performed in the non-fasting state in children with
T1DM and fasting state in children without T1DM, analysis
were performed after recalculation of lipids in case lipids
were non-fasting (in children with T1DM). One of the
reasons for the decision of recalculation of non-fasting
values instead of fasting values is because the Friedewald
formula for calculation of low-density lipoprotein (LDL)
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values [7]. As reported in a recent study investigating
fasting and non-fasting lipid levels in children with T1DM,
mean variation was 0 mmol/L for high-density lipoprotein
(HDL) cholesterol, +0.11 mmol/L for total cholesterol and
−0.31 mmol/L for triglycerides [16]. After recalculation of
aforementioned lipid profiles in children with T1DM,
LDL cholesterol was calculated with the Friedewald
formula [7]. Since the calculation of LDL cholesterol in
T1DM patients has been shown to be less reliable, non-
HDL cholesterol was calculated as well [17]. In children
with T1DM, additional data on insulin regimen, diabetes
duration and HbA1c were collected. Target levels for
HbA1c were defined as HbA1c <7.5% [18]. A positive
family history was defined as a family history positive
for CVD (i.e. occurring before 55 years of age), T2DM
and/or hypertension in a first or second degree family
member [2].
Laboratory analyses
In children with T1DM, non-fasting lipids and ALT were
measured in the non-fasting state by enzymatic methods on
the Hitachi Cobas C501 analyser (Roche, Mannheim,
Germany) with an intra- and inter-assay coefficient of
variation of <2.1% HbA1c. HbA1c was measured by a
immunochemical assay with intra- and inter-assay coef-
ficients of variation of <3.7% and <4.3%, (reference range,
4–6%). In the non-diabetic subjects, plasma glucose, ALT
and lipids were determined with SYNCHRON LX 20
(Beckman Coulter, Galway, Ireland), with intra-assay
coefficients of variation (CV) of ≤3.5% for ALT and ≤3%
for plasma glucose and fasting lipids. LDL cholesterol was
calculated with the Friedewald formula [7]. Plasma insulin
levels were measured by an immunoluminometric assay
(Immulite 200 system, DPC, Los Angeles, CA, USA; intra-
assay variation, 3–6%; inter-assay variation, 3–5%).
Statistical analysis
Data are shown as median [interquartile range (IQR)].
Using power analysis, a sample size of 45 pairs was needed
to detect a difference of 0.3 for LDL cholesterol (SD, 0.8;
power, 80%; alpha, 0.05) and 0.15 for HDL cholesterol
(SD, 0.5; power, 80%; alpha, 0.05). Differences between
case and control groups were tested with generalised
estimating equations models (GEEs), with cardiometabolic
variables, and family history as dependent variables. GEE
instead of ‘paired analysis’ was used since it allows
adjustment for confounders. Results were presented with
and without adjustment for Z-WC. For comparing preva-
lence rates of positive family history between groups,
Fisher exact tests were used. In determining differences for
cardiometabolic risk within the T1DM group (stratified for
glycaemic status, HbA1c<7.5 versus ≥7.5%), independent
Student’s t tests were performed. All analyses were
performed with SPSS 16.0 for windows.
Results
Baseline characteristics
In total, 44 overweight T1DM children could be matched to
44 non-diabetic children. Overall, median age was 12.0
(IQR, 9.1–15.6) years, and median Z-BMI was 2 (IQR,
1.9–2.6). In the T1DM group, median diabetes duration
was 5.85 (IQR, 2.97–9.16) years, and median insulin dose
of 0.96 (IQR, 0.69–1.34) IU/kg/day. Thirty-two children
used insulin pump therapy, while multiple insulin injection
therapy was used by ten children, three children were
treated with a single or two insulin injections. In children
with T1DM, median fasting glucose levels were 5.1 (IQR,
4.9–5.3) mmol/L, and median fasting insulin was 94 (IQR,
69–126) pmol/L.
Differences in cardiometabolic risk factors
between overweight children with and without T1DM
Table 1 lists the cardiometabolic characteristics of the 44
T1DM children and the 44 children without T1DM and
presents recalculated lipid levels for total cholesterol,
triglycerides and LDL cholesterol. Median measured
cholesterol levels in T1DM children were 4.3 (IQR, 3.9–
4.7) mmol/L for total cholesterol and 1.2 (IQR, 0.9–1.6)
mmol/L for triglycerides. Since Z-WC was significantly
lower in children with T1DM [2.0 (IQR, 1.5–2.3) vs. 2.6
(IQR, 2.0–2.9), P<0.001], results with and without adjust-
ment for Z-WC are shown. For both LDL and non-HDL
cholesterol, both recalculated and measured lipid levels
were significantly lower in children with T1DM than in
children without T1DM (all P<0.05). No significant
differences were found between groups for total cholesterol
and triglycerides; however, HDL cholesterol was signifi-
cantly higher in children with T1DM, relative to non-
diabetic children.
The role of glycaemic control in children with T1DM
When T1DM children were divided according to glycaemic
control, 31 had suboptimal control (HbA1c≥7.5%) and 13
had good glycaemic control (HbA1c<7.5%). These groups
did not differ with respect to age and diabetes duration.
Children with suboptimal glycaemic control had higher
Eur J Pediatr (2012) 171:493–498 495values of (non-fasting) triglycerides, LDL cholesterol and
non-HDL cholesterol as compared to well regulated children:
1.3 (IQR, 1.0–1.8) vs. 0.96 (IQR, 0.80–1.18) mmol/L for
triglycerides, 2.8 (IQR, 2.5–3.6) vs. 2.6 (IQR, 2.4–2.7) mmol/
L for LDL cholesterol and 3.0 (IQR, 2.8–3.8) vs. 2.7 (IQR,
2.5–2.8) mmol/L for non-HDL cholesterol, all P<0.05. Blood
pressure and ALT levels were similar across the two T1DM
groups.
Prevalence of a positive family history
Figure 1 shows the prevalence of a positive family history
of CVD, T2DM, hypertension and hypercholesterolaemia.
Overall, a positive family history for any of aforementioned
diseases was present in 34 children with T1DM, against 10
in the non-T1DM overweight group (P<0.001). Having a
positive family history for either cardiometabolic disease
did not associate with a more adverse cardiometabolic risk
profile (data not shown).
Discussion
This is the first study comparing cardiometabolic risk
parameters in overweight children with and without
T1DM. It is shown that overweight children with T1DM
have lower waist circumference, higher levels of HDL
cholesterol and lower levels of LDL cholesterol as
compared to non-diabetic controls, but similar blood
pressure and ALT values.
The difference between visceral fat (as measured by
waist circumference) between overweight T1DM and non-
diabetic children has not been described before, and the
Fig. 1 Prevalence of a positive family history in overweight children
with and without T1DM. *P<0.001. T2DM Type 2 diabetes mellitus,
CVD cardiovascular disease, HT hypertension, HC hypercolesterolae-
mia. Analysis with Fisher’s exact test
Table 1 Cardiometabolic variables in overweight children with T1DM as compared to non-diabetic children
T1DM overweight Non-T1DM overweight P value P value
a
N 44 44
Sex, boys, n (%) 15 15 −−
Age (years) 12.0 (9.1–15.8) 12.1 (9.2–15.1) −−
Age >11 years, n (%) 18 17 −−
BMI (kg/m
2) 23.3 (20.8–27.0) 25.0 (21.7–28.0) −−
Z-BMI 2.3 (1.9–2.6) 2.4 (2.1–2.7) −−
Waist 77.8 (69.0–88.0) 86.5 (72.5–96.0) <0.001 <0.001
Z-WC 2.0 (1.5–2.3) 2.6 (2.0–2.9) <0.001 −
Systolic blood pressure (mmHg) 118 (104–127) 112 (110–123) 1.00 0.20
Diastolic blood pressure (mmHg) 69 (65–74) 70 (66–75) 0.04 0.14
Total cholesterol (mmol/L)
b 4.3 (3.9–4.7) 4.6 (4.0–4.9) 0.30 0.16
HDL cholesterol (mmol/L) 1.3 (1.1–1.4) 1.2 (1.0–1.3) <0.001 <0.001
LDL cholesterol (mmol/L)
b 2.7 (2.5–3.2) 3.0 (2.5–3.4) 0.011 0.01
Triglycerides (mmol/L)
b 0.9 (0.6–1.5) 0.9 (0.6–1.5) 0.80 0.69
non-HDL cholesterol (mmol/L)
b 2.9 (2.7–3.5) 3.5 (2.8–3.9) 0.03 0.05
ALT (IU/L) 20 (15–24) 21 (16–27) 0.49 0.63
Tested with generalised estimating equations model. Data expressed as median (interquartile range). To convert values for cholesterol to
millimoles per liter, multiply by 0.02586. To convert values for triglycerides to millimoles per liter, multiply by 0.01129
Z-BMI Standard deviation score of BMI, Z-WC standard deviation score of waist circumference, ALT alanine aminotransferase, HDL high-density
lipoprotein, LDL low density lipoprotein
aModels additionally adjusted for Z-WC
bRecalculated values from non-fasting state in T1DM children
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the children were matched for sex, age, ethnicity and BMI,
none of these factors are responsible. Moreover, the percent-
ageofpubertalchildrenwassimilarinbothgroups.Therefore,
other factors, like diet, physical activity and the nature of
overweight(i.e.duetowell-controlleddiabetesvs.asedentary
lifestyle), are likely to have caused the difference in body fat
distribution. The differences in the nature of weight gain is
substantiated by the finding that children with T1DM become
more frequently overweight, but not obese, emphasising a
different pathophysiological mechanism [9].
Part of the finding of a more favourable lipid profile in
T1DM children as compared to non-diabetic children was
already established in the SEARCH for Diabetes in Youth
study, which reported higher HDL cholesterol levels
(irrespective of glycaemic control) in children with diabetes
as compared to their peers without diabetes [8]. In the same
study, the suboptimal glycaemic control group showed
higher total and LDL cholesterol levels, as compared to
both the control and optimal glycaemic control group [8].
Glycaemic control is directly related to lipid metabolism, i.e.
hypertriglyceridaemiaiscausedbyarelativelackofcirculating
insulin, which results in unsuppressed lipolysis, a subsequent
increase in freefatty acids, leading to an increased hepatic very
LDL (VLDL) triglyceride output and an increased LDL
cholesterol [4, 13]. On the other hand, in well-controlled
patients with T1DM, VLDL production is down-regulated
due to augmented plasma insulin levels [20, 24].
In the present study, we found a majority of children to
have a suboptimal glycaemic control and confirmed the
association between suboptimal glycaemic control and an
adverse lipid profile.
However, in spite of the large proportion of suboptimal
controlled T1DM children, differences in lipid profiles
between overweight children with and without T1DM
become evident and may indicate an even greater difference
between well-controlled overweight T1DM children and
non-diabetic overweight controls.
The explanation for a more favourable lipid profile in
T1DM children is probably also embedded in lifestyle
differences and the nature of overweight (i.e. due to good
glycaemic control). In line with the results of the Diabetes
Control and Complications Trial, our previous study among
283 lean and overweight children with T1DM showed that
overweight children with T1DM had higher blood pressure
values, while having similar mean lipid levels in comparison
to their peers of normal weight [22]. In contrast, in the same
study, a trend was seen for adverse changes in lipid profile in
obese children (Z-BMI, >2) as compared to normal weight
children.
In the present study, we found high absolute numbers of
a positive family history for cardiometabolic risk factors in
the T1DM group. However, only the difference between a
positive history for T2DM was significant between the
T1DM and non-T1DM group. Since the included number
of children is small, we are not able to compare this
outcome to population based studies, such as the Bogalusa
Heart study, which reported a positive family history for
diabetes in 6% for normoglycaemic children and 9% for
children with pre-diabetes [12]. The differences found
(although mostly not significant) between the number of
children having a positive family history between the
T1DM and non-T1DM group may be due to a selection
bias in the specialised diabetes clinic. It may well be that
individuals familiar with the medical circuit (i.e. in families
of children with a positive family history) are more focused
on specialised care for their children.
There is a lack of studies investigating the difference for
cardiometabolic outcomes between overweight populations
with and without T1DM. A recent study by Franks et al.,
among a cohort of 4,857 American Indian non-diabetic
children, with a mean follow-up of 23.9 years, showed that
total cholesterol levels were not associated with premature
death of endogenous causes, whereas for BMI, blood
pressure and glucose intolerance, strong associations were
found [5]. However, in the same study, other lipid levels
(triglycerides, HDL cholesterol and LDL cholesterol) were
not determined, and therefore, no conclusions could be
drawn with respect to these measures and cardiometabolic
outcome. In conclusion, since the role of lipid abnormalities
in youth without diabetes in predicting cardiometabolic
health outcome remains unknown, no extrapolations can be
madetowardsspecific populations(i.e. overweight individuals
with T1DM) between theassociationof lipid profile and actual
cardiometabolic risk.
Some limitations of this study should be mentioned. First
of all, the study was mostly underpowered for detecting
between group differences. In fact, our study results
showed smaller values for the correlation of LDL and
HDL cholesterol leading to a power of 65–70% and thus
the requirement of a larger sample size. Despite this fact,
we were still able to show differences between groups.
Therefore, the true differences are expected to be even
larger than presented in our study. Another limitation is that
lipid levels were measured non-fasting in children with
T1DM, a challenge that was overcome by recalculating non-
fasting lipid total cholesterol, triglyceride levels and LDL
cholesterol. We believe that the potential bias introduced by
this method is minimal, since differences for total and
LDL cholesterol were already found also without re-
calculation of non-fasting lipid levels. In addition, the study
by Margeirsdottir et al. found no difference between fasting
and non-fasting lipid levels for HDL and LDL cholesterol
levels in 50 children with T1DM in whom they tested both
[10]. The strength of this study is the study design, which
enables to provide outcomes that are unlikely to be biased by
Eur J Pediatr (2012) 171:493–498 497the factors matched for (ethnicity, age, Z-BMI and sex).
However, a limitation may be that additional bias could have
occurred with Z-BMI, since children with a wide range of Z-
BMI were included and different results may have been
found when using patients with a Z-BMI at one end of the
spectrum. Additionally, the study design is not suitable for
determining the effect of increasing BMI on the difference in
lipid values between the two study groups. Therefore, this
study is not capable of predicting the difference in lipid
profiles between children with- and without T1DM with
increasing BMI values. Finally, since Tanner stages were not
recorded, we cannot be certain of an equal number of
pubertal children in both groups, which might be partly
responsible for the difference in Z-WC found between
T1DM and non-T1DM children. However, since children
were matched on age, ethnicity and sex, a significant
difference would be unlikely.
In conclusion, overweight children with T1DM show a
more favourable cardiometabolic risk profile as compared
to children without T1DM. Moreover, family history for
cardiometabolic outcomes was more prevalent among
children with T1DM as compared to non-diabetic children.
Longitudinal studies among overweight paediatric cohorts
(with and without T1DM) are needed to quantify actual
differences for cardiometabolic health between these groups
in later life.
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